Lunchtime Symposium
Thursday, 4 September 2025 | Kleist
| 12:30 – 13:30 | Tailoring Neuropathic Pain Management: Insights, Strategies, and Patient-Centered Approaches |
|---|
| Chair | Ralf Baron (Germany) |
| 12:30 | Welcome & Introductions | Ralf Baron (Germany) |
| 12:35 | Enhancing Guideline-Based Treatment in Neuropathic Pain with Phenotyping-Informed Approaches | Andrea Truini (Italy) |
| 12:55 | Management of Painful Diabetic Neuropathy: insights from OPTION-DM trial | Solomon Tesfaye (UK) |
| 13:15 | Q&A | |
Lunchtime Symposium
Friday, 5 September 2025 | Humboldt
| 12:30 – 13:30 | VER-01 – A Paradigm Shift in the Pharmacological Treatment of Chronic Low Back Pain? |
|---|
| Chair | Ralf Baron (Germany) |
| 12:30 | Challenges in the pharmacological treatment of chronic low back pain | Ralf Baron (Germany) |
| 12:50 | Pivotal phase 3 data on the efficacy and safety of VER-01 in chronic low back pain | Charles Argoff (USA) |
| 13:20 | Q&A | |
Mini Symposium
Friday, 5 September 2025 | Voltaire
| 12:30 – 13:00 | Beyond Conventional Medical Management: Innovative Therapies for neuropathic pain and refractory cancer pain management |
|---|
| 12:30 | Beyond Conventional Medical Management: Innovative Therapies for neuropathic pain and refractory cancer pain management | Sam Eldabe (UK) |